Advancing translational cancer research
- Nov. 8, 2011
-
LivTech Inc. and Yakult Honsha Co.,Ltd. entered into an Option Agreement for LIV-2008 Project
- Dec. 7, 2010
-
The termination of LIV-1205 license agreement between LivTech Inc. and Kyowa Hakko Kirin Co., Ltd.
- Aug. 9, 2010
- President, Representative Director Dr. Nakamura is an invited speaker at Japan BiotechForum:London 2010 on September 9th in London, and attending BioPharmaAmerica conference in Boston (Sept. 15-17th) as a presenter.
in Lndon:Sept. 9th
in Boston: Sept. 15-17th
- Aug. 14, 2009
- LivTech was recognized by NEDO (New Energy and Industrial Technology Development Organization)’s 2nd Research Grant Program 2009 as one of the excelling innovative enterprises in Japan
Click here for details (in Japanese only)
- Feb. 26, 2008
-
LivTech has licensed its anti-cancer antibody to Kyowa Hakko Kirin
Click here for details (in Japanese only)